20(R)-Ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity

Jie Liu, Jun Shiono, Kuniyoshi Shimizu, Hongshan Yu, Chunzhi Zhang, Fengxie Jin, Ryuichiro Kondo

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Increased osteoclastic bone resorption plays a central role in the pathogenesis of many bone diseases, and osteoclast inhibitors are the most widely used treatments for these diseases. Ginsenosides, the main component of ginseng, have been known for their medicinal effects such as anti-inflammatory and anti-proliferative activities. In this study, we investigated the inhibitory effects of ginsenosides (ginsenoside 20(R)-Rh2 and ginsenoside 20(S)-Rh2) on osteoclastgenesis using RAW264 cells in vitro. Only ginsenoside 20(R)-Rh2 showed selective osteoclastgenesis inhibitory activity without any cytotoxicity up to 100 μM. These results implied that the stereochemistry of the hydroxyl group at C-20 may play an important role in selective osteoclastgenesis inhibitory activity.

Original languageEnglish
Pages (from-to)3320-3323
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume19
Issue number12
DOIs
Publication statusPublished - Jun 15 2009

Fingerprint

Ginsenosides
Cytotoxicity
Bone
Panax
Stereochemistry
Bone Diseases
Osteoclasts
Bone Resorption
Hydroxyl Radical
Anti-Inflammatory Agents
ginsenoside Rh2

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

20(R)-Ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity. / Liu, Jie; Shiono, Jun; Shimizu, Kuniyoshi; Yu, Hongshan; Zhang, Chunzhi; Jin, Fengxie; Kondo, Ryuichiro.

In: Bioorganic and Medicinal Chemistry Letters, Vol. 19, No. 12, 15.06.2009, p. 3320-3323.

Research output: Contribution to journalArticle

Liu, Jie ; Shiono, Jun ; Shimizu, Kuniyoshi ; Yu, Hongshan ; Zhang, Chunzhi ; Jin, Fengxie ; Kondo, Ryuichiro. / 20(R)-Ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity. In: Bioorganic and Medicinal Chemistry Letters. 2009 ; Vol. 19, No. 12. pp. 3320-3323.
@article{aa747f7ee190407ab02f69dae29d7e3f,
title = "20(R)-Ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity",
abstract = "Increased osteoclastic bone resorption plays a central role in the pathogenesis of many bone diseases, and osteoclast inhibitors are the most widely used treatments for these diseases. Ginsenosides, the main component of ginseng, have been known for their medicinal effects such as anti-inflammatory and anti-proliferative activities. In this study, we investigated the inhibitory effects of ginsenosides (ginsenoside 20(R)-Rh2 and ginsenoside 20(S)-Rh2) on osteoclastgenesis using RAW264 cells in vitro. Only ginsenoside 20(R)-Rh2 showed selective osteoclastgenesis inhibitory activity without any cytotoxicity up to 100 μM. These results implied that the stereochemistry of the hydroxyl group at C-20 may play an important role in selective osteoclastgenesis inhibitory activity.",
author = "Jie Liu and Jun Shiono and Kuniyoshi Shimizu and Hongshan Yu and Chunzhi Zhang and Fengxie Jin and Ryuichiro Kondo",
year = "2009",
month = "6",
day = "15",
doi = "10.1016/j.bmcl.2009.04.054",
language = "English",
volume = "19",
pages = "3320--3323",
journal = "Bioorganic and Medicinal Chemistry Letters",
issn = "0960-894X",
publisher = "Elsevier Limited",
number = "12",

}

TY - JOUR

T1 - 20(R)-Ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity

AU - Liu, Jie

AU - Shiono, Jun

AU - Shimizu, Kuniyoshi

AU - Yu, Hongshan

AU - Zhang, Chunzhi

AU - Jin, Fengxie

AU - Kondo, Ryuichiro

PY - 2009/6/15

Y1 - 2009/6/15

N2 - Increased osteoclastic bone resorption plays a central role in the pathogenesis of many bone diseases, and osteoclast inhibitors are the most widely used treatments for these diseases. Ginsenosides, the main component of ginseng, have been known for their medicinal effects such as anti-inflammatory and anti-proliferative activities. In this study, we investigated the inhibitory effects of ginsenosides (ginsenoside 20(R)-Rh2 and ginsenoside 20(S)-Rh2) on osteoclastgenesis using RAW264 cells in vitro. Only ginsenoside 20(R)-Rh2 showed selective osteoclastgenesis inhibitory activity without any cytotoxicity up to 100 μM. These results implied that the stereochemistry of the hydroxyl group at C-20 may play an important role in selective osteoclastgenesis inhibitory activity.

AB - Increased osteoclastic bone resorption plays a central role in the pathogenesis of many bone diseases, and osteoclast inhibitors are the most widely used treatments for these diseases. Ginsenosides, the main component of ginseng, have been known for their medicinal effects such as anti-inflammatory and anti-proliferative activities. In this study, we investigated the inhibitory effects of ginsenosides (ginsenoside 20(R)-Rh2 and ginsenoside 20(S)-Rh2) on osteoclastgenesis using RAW264 cells in vitro. Only ginsenoside 20(R)-Rh2 showed selective osteoclastgenesis inhibitory activity without any cytotoxicity up to 100 μM. These results implied that the stereochemistry of the hydroxyl group at C-20 may play an important role in selective osteoclastgenesis inhibitory activity.

UR - http://www.scopus.com/inward/record.url?scp=65749114119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65749114119&partnerID=8YFLogxK

U2 - 10.1016/j.bmcl.2009.04.054

DO - 10.1016/j.bmcl.2009.04.054

M3 - Article

C2 - 19428246

AN - SCOPUS:65749114119

VL - 19

SP - 3320

EP - 3323

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

SN - 0960-894X

IS - 12

ER -